Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer

by Lianidou, E S, Mavroudis, D, Georgoulias, V
Published 2013

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

by Androulakis, N, Agelaki, S, Perraki, M, Apostolaki, S, Bozionelou, V, Pallis, A, Kalbakis, K, Xyrafas, A, Mavroudis, D, Georgoulias, V
Published 2012

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

by Xenidis, N, Perraki, M, Apostolaki, S, Agelaki, S, Kalbakis, K, Vardakis, N, Kalykaki, A, Xyrafas, A, Kakolyris, S, Mavroudis, D, Georgoulias, V
Published 2013

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt,...

by Saridaki, Z, Androulakis, N, Vardakis, N, Vamvakas, L, Kabouraki, E, Kalbakis, K, Hatzidaki, D, Voutsina, A, Mavroudis, D, Georgoulias, V, Souglakos, J
Published 2012

A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy

by Kotsakis, A, Matikas, A, Koinis, F, Kentepozidis, N, Varthalitis, I I, Karavassilis, V, Samantas, Ep, Katsaounis, P, Dermitzaki, E K, Hatzidaki, D, Mavroudis, D, Georgoulias, V
Published 2016

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

by Papadaki, C, Sfakianaki, M, Lagoudaki, E, Giagkas, G, Ioannidis, G, Trypaki, M, Tsakalaki, E, Voutsina, A, Koutsopoulos, A, Mavroudis, D, Georgoulias, V, Souglakos, J
Published 2014